封面
市场调查报告书
商品编码
1588460

压缩机雾化器市场规模、份额和趋势分析报告:按适应症、最终用途、地区、细分市场预测,2025-2030 年

Pneumatic Nebulizers Market Size, Share & Trends Analysis Report By Indication (Breath-actuated, Vented), By End-use (Hospitals & Clinics, Home Healthcare), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

压缩机雾化器市场成长与趋势:

根据Grand View Research, Inc.最新报告,预计2030年全球压缩机雾化器市场规模将达11.6674亿美元,2025年至2030年复合年增长率为6.5%。

近年来,随着家庭医疗保健设备的普及,压缩机式雾化器的市场采用量出现了一定的成长。产品小型化和技术进步也推动了家庭医疗保健设备的采用。

据明尼苏达州卫生署称,与其他产生气溶胶的手术相比,使用雾化器给药的感染风险较低。另一方面,根据 ISAM 的说法,雾化器产生的气溶胶不携带患者来源的病毒颗粒,因为它们源自于雾化室中的液体,而雾化室中的液体不是患者来源。只有当医护人员或病患污染了雾化器时,雾化器产生的气溶胶才含有病原体。儘管各机构提出了各种建议,但尚不清楚在大流行期间是否适合使用雾化器。

然而,尚无已知的雾化器被动感染案例。即使有感染风险,也可以透过采取适当的 COVID-19 预防措施来避免。因此,疫情对整个市场仅产生了一定的影响。革命性的技术进步正在迅速改变市场。这种扩张正在创造利润丰厚的可能性。例如,2019 年 3 月,Breath Technologies 宣布启动 L-CSA-i 的 3 期波士顿临床试验,透过 PARI Pharma 的研究药物特异性eFlow 雾化器治疗阻塞性细支气管炎症候群。

压缩机雾化器市场报告亮点

  • 据显示,2024 年呼吸驱动细分市场的收益占有率64.06%。呼吸驱动雾化器具有更高的药物传输能力和更低的剂量浪费。因此,提供先进吸入疗法的细分市场预计将在预测期内主导市场。
  • 2024 年,医院和诊所细分市场占据最大市场占有率。越来越多地采用压缩机动力雾化器来治疗气喘和慢性阻塞性肺病(COPD) 等急性呼吸道疾病,这推动了该行业的成长。
  • 北美压缩机雾化器市场在 2024 年占据主导地位,收益占有率为 35.28%,由于呼吸系统疾病盛行率的增加和雾化器技术的进步,预计在预测期内将出现增长。
  • 预计亚太地区在预测期内将以最快的复合年增长率成长。亚洲慢性阻塞性肺病的负担比西方已开发国家更大。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章 指标业务分析

  • 2024年及2030年指示市场占有率
  • 指示细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析(依指标)
  • 呼吸激活
  • 发洩

第五章 最终用途业务分析

  • 2024 年及 2030 年最终用途市场占有率
  • 最终用途细分仪表板
  • 2018-2030 年按最终用途分類的市场规模、预测与趋势分析
  • 医院/诊所
  • 家庭保健

第 6 章 区域估计/趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析:
  • 北美洲
    • 2018-2030年北美压缩机式雾化器市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲压缩机式雾化器市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 2018-2030 年亚太地区压缩机雾化器市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030年拉丁美洲压缩机式雾化器市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东和非洲气动雾化器市场估计与预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与企业概况
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介
    • Koninklijke Philips NV
    • OMRON Corporation
    • Cook Medical PARI GmbH
    • General Electric
    • Allied Healthcare Products, Inc.
    • BD(Becton, Dickinson &Company)
    • GF Health Products, Inc.
    • Medline Industries, LP
    • Briggs Healthcare
    • Vectura Group Ltd
Product Code: GVR-1-68038-194-8

Pneumatic Nebulizers Market Growth & Trends:

The global pneumatic nebulizers market size is expected to reach USD 1,166.74 million by 2030, registering a CAGR of 6.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has shown constant growth in the adoption of pneumatic nebulizers as home healthcare devices have been gaining popularity in recent years. Miniaturization of products and technological advancements are also boosting the adoption of home healthcare devices.

As per the Minnesota Department of Health, administration of medication through nebulizer represents a lower infection risk as compared to other aerosol-producing procedures. On the other hand, according to ISAM, aerosols from the nebulizer do not carry viral particles derived from the patient as they are generated from the fluid in the nebulized chamber, which is a non-patient source. Aerosols generated by nebulizers comprise pathogens only when the healthcare workers or patients contaminate the nebulizers. Various recommendations from institutes do not clarify whether it is appropriate to use nebulizers during the pandemic.

However, there are no known cases of passive infection due to nebulizers. Also, the risk of infection, if any, can be avoided if proper COVID-19 precautions are taken. Therefore, the pandemic affected the overall market only to a certain extent. Revolutionary technological progress is rapidly transforming the market. These expansions are producing lucrative potentials. For instance, in March 2019, Breath Technologies announced the initiation of Phase 3 BOSTON clinical study of L-CsA-i for the treatment of bronchiolitis obliterans syndrome via a drug-specific eFlow nebulizer of PARI Pharma that is under investigation.

Pneumatic Nebulizers Market Report Highlights:

  • Based on indication, the breath-actuated segment held the largest revenue share 64.06% in 2024. Breath-actuated nebulizers elucidate higher drug delivery capacity and lesser dosage wastage features. Thus, the segment delivering advanced inhalation therapy is expected to dominate the market over the forecast period.
  • Hospitals & clinics segment held the largest market share in 2024. The increasing adoption of pneumatic nebulizers for the management of acute respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) is fueling the segment growth.
  • North America pneumatic nebulizers market dominated with a revenue share of 35.28% in 2024 and is poised to grow over the forecast period owing to the increasing prevalence of respiratory diseases and advancements in nebulizer technology.
  • Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The burden of COPD in Asia is greater than that in developed Western countries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Indication
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
    • 3.2.5. Industry Analysis - Porter's Five Forces Analysis
      • 3.2.5.1. Supplier power
      • 3.2.5.2. Buyer power
      • 3.2.5.3. Substitution threat
      • 3.2.5.4. Threat of new entrant
      • 3.2.5.5. Competitive rivalry
    • 3.2.6. PESTLE Analysis

Chapter 4. Indication Business Analysis

  • 4.1. Indication Market Share, 2024 & 2030
  • 4.2. Indication Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 4.4. Breath-actuated
    • 4.4.1. Breath-actuated market, 2018 - 2030 (USD Million)
  • 4.5. Vented
    • 4.5.1. Vented market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market, 2018 - 2030 (USD Million)
  • 5.5. Home Healthcare
    • 5.5.1. Home healthcare market, 2018 - 2030 (USD Million)

Chapter 6. Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework/reimbursement scenario
      • 6.4.2.3. U.S. pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework/reimbursement scenario
      • 6.4.3.3. Canada pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework/reimbursement scenario
      • 6.4.4.3. Mexico pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework/reimbursement scenario
      • 6.5.2.3. UK pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework/reimbursement scenario
      • 6.5.3.3. Germany pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework/reimbursement scenario
      • 6.5.4.3. France pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework/reimbursement scenario
      • 6.5.5.3. Italy pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework/reimbursement scenario
      • 6.5.6.3. Spain pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework/reimbursement scenario
      • 6.5.7.3. Norway pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework/reimbursement scenario
      • 6.5.8.3. Denmark pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework/reimbursement scenario
      • 6.5.9.3. Sweden pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework/reimbursement scenario
      • 6.6.2.3. Japan pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework/reimbursement scenario
      • 6.6.3.3. China pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework/reimbursement scenario
      • 6.6.4.3. India pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework/reimbursement scenario
      • 6.6.5.3. South Korea pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework/reimbursement scenario
      • 6.6.6.3. Australia pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework/reimbursement scenario
      • 6.6.7.3. Thailand pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework/reimbursement scenario
      • 6.7.2.3. Brazil pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework/reimbursement scenario
      • 6.7.3.3. Argentina pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework/reimbursement scenario
      • 6.8.2.3. South Africa pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework/reimbursement scenario
      • 6.8.3.3. Saudi Arabia pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework/reimbursement scenario
      • 6.8.4.3. UAE pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework/reimbursement scenario
      • 6.8.5.3. Kuwait pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Koninklijke Philips N.V.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. OMRON Corporation
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Cook Medical PARI GmbH
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. General Electric
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Allied Healthcare Products, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. BD (Becton, Dickinson & Company)
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. GF Health Products, Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Medline Industries, LP
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Briggs Healthcare
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Vectura Group Ltd
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 4 North America pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 6 North America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 8 U.S. pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 10 Canada pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Mexico pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 12 Mexico pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Europe pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Europe pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 17 UK pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Germany pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 19 Germany pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 20 France pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 21 France pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Italy pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Italy pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Spain pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 25 Spain pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 27 Norway pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Denmark pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Denmark pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Sweden pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 31 Sweden pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 36 Japan pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 China pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 38 China pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 39 India pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 40 India pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 42 Australia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 South Korea pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 44 Thailand pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Thailand pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 46 Latin America pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 48 Latin America pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 50 Brazil pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 52 Argentina pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa pneumatic nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 55 MEA pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 57 South Africa pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 61 UAE pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait pneumatic nebulizers market, by indication, 2018 - 2030 (USD Million)
  • Table 63 Kuwait pneumatic nebulizers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Pneumatic nebulizers market: Indication outlook and key takeaways
  • Fig. 15 Pneumatic nebulizers market: Indication movement analysis
  • Fig. 16 Breath-actuated market, 2018 - 2030 (USD Million)
  • Fig. 17 Vented market, 2018 - 2030 (USD Million)
  • Fig. 18 Pneumatic nebulizers market: End use outlook and key takeaways
  • Fig. 19 Pneumatic nebulizers market: End use movement analysis
  • Fig. 20 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 21 Home healthcare market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional marketplace: Key takeaways
  • Fig. 23 Regional outlook, 2024 & 2030
  • Fig. 24 Pneumatic nebulizers market: Region movement analysis
  • Fig. 25 North America pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 30 UK pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 31 Germany pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 32 France pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 35 Spain pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 36 Norway pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 40 Japan pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 41 China pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 42 India pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 43 Australia pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait pneumatic nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 54 Company categorization
  • Fig. 55 Strategy mapping
  • Fig. 56 Company market position analysis